Topic: Jynneos

Dr. Peter McCullough reports that the JYNNEOS monkeypox vaccine, of which the U.S. government purchased 13 million doses, has known links to heart inflammation. Concerns are raised regarding the marketing of this live attenuated vaccine to immunocompromised individuals, specifically those with HIV, who may face higher risks from such treatments.

Documents suggest that the Jynneos vaccine, originally intended for smallpox, had monkeypox added to its indication in 2019 at the request of U.S. government stakeholders. The timing of this regulatory change occurs three years prior to the current outbreak, raising questions about government foresight or corruption.